Cycurion, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between August 28, 2025, and September 29, 2025, for Cycurion, Inc. (NASDAQ: CYCU). The filing details a material amendment to a stock-for-stock exchange agreement with iQSTEL, Inc., and significant corporate governance actions approved by stockholders via written consent, including board elections, auditor ratification, and charter amendments.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The primary financial data points relate to specific transaction values and capital structure adjustments:
- Stock Exchange Value: A mutual exchange of $1,000,000 worth of common stock between Cycurion and iQSTEL.
- Share Issuance: Cycurion to issue 3,866,976 shares to iQSTEL; iQSTEL to issue 151,058 shares to Cycurion.
- Dividend Obligation: Each party has a $500,000 dividend obligation to its shareholders, payable in shares received from the counterparty or equivalent value of their own stock.
- Capital Structure: Authorized common stock increased from 100,000,000 to 300,000,000 shares.
- Outstanding Shares (as of Aug 13, 2025): 51,700,173 common shares and 114,851 preferred voting shares (convertible to 17,430,424 common shares).
Material Changes
The following material changes were executed or approved during the reporting period:
- Amendment to Stock-for-Stock Agreement: The timeline for the closing of the iQSTEL exchange was extended from 30 to 60 business days. A firm deadline of December 15, 2025, was set for regulatory filings to enable a dividend distribution by December 31, 2025. Dividend payment methods were expanded to allow distribution of either received shares or the company's own authorized stock.
- Charter Amendment: The Company's Certificate of Incorporation was amended to increase authorized common stock to 300,000,000 shares and to authorize reverse stock splits with a ratio between 3:1 and 75:1 (aggregate not exceeding 250:1).
- Equity Plan Increase: The number of shares authorized under the 2025 Equity Incentive Plan was increased from 10,000,000 to 25,000,000.
- Board Composition: Six new directors were elected to serve until the 2026 annual meeting.
Outlook, Risks, and Management Commentary
Management has established a strict timeline to complete the iQSTEL transaction, with a December 31, 2025, target for dividend distribution. The filing notes that any share distributions must comply with federal and state securities laws and Nasdaq listing rules. The approval of reverse stock split authority suggests management is preparing for potential capital structure optimization to maintain listing compliance or improve share price metrics. No specific forward-looking revenue guidance or risk factors beyond standard regulatory compliance were detailed in this specific filing.
Investor Verification Checklist
- Verify the final closing date of the iQSTEL stock exchange and the method of dividend distribution (received shares vs. own shares).
- Monitor the December 15, 2025, deadline for regulatory filings related to the iQSTEL transaction.
- Confirm the specific reverse stock split ratio, if and when implemented, given the broad 3:1 to 75:1 authorization.
- Review the impact of the increased equity plan authorization (25,000,000 shares) on potential future dilution.
- Check subsequent filings for the actual issuance of the 3,866,976 Cycurion shares to iQSTEL.